GSK plc
GLAXF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $70.1M in total; no superinvestor holds it.
Other share classesGSK
Key figures
- Market capADS ratio not in SEC data
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 2
- 13F valueReported value at the end of Q2 2026
- $70.1M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in GBP.
- Revenue, FY2025
- GBP 32.7B
- +4.1% year over year
- Net income, FY2025
- GBP 6.29B
- +113.1% year over year
- Free cash flow, FY2025
- GBP 6.39B
- +24.0% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.25M
- Shares sold short
- Change
- +44.6K
- +3.7% vs. previous
- Days to cover
- > 999
- Above FINRA's cap of 999.99 days
Superinvestors holding GLAXF, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding GLAXF at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by GSK plc insiders from Form 4, newest first.
No open-market purchases or sales by GSK plc insiders are on file.
Top 10 13F holders, Q2 2026
See all 2 holdersThe largest institutional positions in GSK plc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aristotle Capital Management, LLC | 2,633,914 | $69.3M | 0.15% | −190,807−6.8% | Reduced |
| Generali Investments CEE, investicni spolecnost, a.s. | 34,105 | $895.8K | 0.04% | −4,209−11.0% | Reduced |
Holders of 5% or more of GLAXF
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of GSK plc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 8.90%369.6M shares | – | Mar 7, 20251 filing | Mar 7, 2025 | SEC |
| FMR LLC | 13G | 5.80%234.9M shares | New | May 6, 20261 filing | May 6, 2026 | SEC |
Politician trades
All politician trades in GLAXF12 members of Congress reported 45 trades in GSK plc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 21, 2026 | Alan Armstrong Senate · OK | Buy | $15K-$50K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Buy | $1K-$15K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |
| Oct 10, 2025 | Val T. Hoyle House · OR | Sell | $1K-$15K |

Senate · OK · Jul 21, 2026
Buy$15K-$50K

House · MI · Nov 21, 2025
Sell$1K-$15K

House · MI · Nov 21, 2025
Buy$1K-$15K

House · MI · Nov 21, 2025
Sell$1K-$15K

House · OR · Oct 10, 2025
Sell$1K-$15K